| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | EPS8 MICAL1 EPS8L2 SYNE1 INPPL1 SPTBN2 SPTBN5 DST ANLN TLN1 DAAM2 DAAM1 DMD | 6.89e-06 | 479 | 121 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.94e-05 | 13 | 121 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.39e-04 | 17 | 121 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EPS8L2 ANK3 BZW2 SPTBN2 LRRC4C S1PR3 PTPN2 DST ANLN TLN1 DMD TJP3 | 2.84e-04 | 599 | 121 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EPS8 MICAL1 EPS8L2 ANK3 HAP1 SYNE1 INPPL1 SPTBN2 JAKMIP3 SPTBN5 DST ANLN TLN1 DAAM2 DAAM1 DMD KIF13A | 3.38e-04 | 1099 | 121 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 3.52e-04 | 23 | 121 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 4.43e-04 | 372 | 121 | 9 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 7.19e-04 | 398 | 121 | 9 | GO:0061659 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | ANK3 HAP1 SLC9B1P1 SPG11 CHRNA7 SLC9B1 NPHP3 IFT52 DST ZMYND10 KIF13A DNAH5 DYNC1H1 CCDC40 | 1.09e-06 | 493 | 120 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.30e-06 | 253 | 120 | 10 | GO:0099111 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 3.34e-06 | 154 | 120 | 8 | GO:0007368 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 4.86e-06 | 162 | 120 | 8 | GO:0060972 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 5.56e-06 | 165 | 120 | 8 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 5.56e-06 | 165 | 120 | 8 | GO:0009799 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 3.06e-05 | 11 | 120 | 3 | GO:0035095 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPS8 TBC1D15 EPS8L2 HAP1 SYNE1 INPPL1 C2CD3 NPHP3 IFT52 ZMYND10 ANLN DAAM2 DNAH5 CCDC40 | 3.56e-05 | 670 | 120 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | microtubule-based process | ANK3 HAP1 SLC9B1P1 SPG11 XPO1 CHRNA7 AXIN1 SLC9B1 C2CD3 NPHP3 IFT52 DST ZMYND10 UHRF1 KIF13A DNAH5 DYNC1H1 CCDC40 | 3.99e-05 | 1058 | 120 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPS8 TBC1D15 EPS8L2 HAP1 SYNE1 INPPL1 C2CD3 NPHP3 IFT52 ZMYND10 ANLN DAAM2 DNAH5 CCDC40 | 4.53e-05 | 685 | 120 | 14 | GO:0030031 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 1.03e-04 | 248 | 120 | 8 | GO:0120032 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 1.12e-04 | 251 | 120 | 8 | GO:0060491 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 1.24e-04 | 44 | 120 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | cilium movement | 1.46e-04 | 261 | 120 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 1.56e-04 | 197 | 120 | 7 | GO:0010970 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.88e-04 | 203 | 120 | 7 | GO:0030534 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 2.70e-04 | 98 | 120 | 5 | GO:0008088 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 2.92e-04 | 289 | 120 | 8 | GO:0000209 | |
| GeneOntologyBiologicalProcess | determination of pancreatic left/right asymmetry | 3.32e-04 | 5 | 120 | 2 | GO:0035469 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 3.51e-04 | 225 | 120 | 7 | GO:0030705 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 3.56e-04 | 24 | 120 | 3 | GO:0008090 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPS8 TBC1D15 EPS8L2 HAP1 SYNE1 INPPL1 TSC1 LRRC4C CHRNA3 BRAF ZMYND10 ANLN DAAM2 DMD | 4.07e-04 | 846 | 120 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | walking behavior | 4.13e-04 | 60 | 120 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPS8 TBC1D15 EPS8L2 HAP1 SYNE1 INPPL1 TSC1 LRRC4C CHRNA3 BRAF ZMYND10 ANLN DAAM2 DMD | 4.96e-04 | 863 | 120 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | neurotrophin production | 4.96e-04 | 6 | 120 | 2 | GO:0032898 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 4.96e-04 | 6 | 120 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | determination of liver left/right asymmetry | 4.96e-04 | 6 | 120 | 2 | GO:0071910 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 5.94e-04 | 66 | 120 | 4 | GO:0030042 | |
| GeneOntologyCellularComponent | cell cortex | 6.06e-05 | 371 | 121 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.45e-04 | 18 | 121 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | cholinergic synapse | 2.69e-04 | 22 | 121 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.61e-04 | 477 | 121 | 10 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.94e-04 | 503 | 121 | 10 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynapse | EPS8 ANK3 HAP1 SYNE1 SPTBN2 MPDZ TSC1 LRRC4C CHRNA3 CHRNA5 CHRNA7 DST SLC24A2 PLEKHA5 DMD | 7.99e-04 | 1018 | 121 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | 9.34e-04 | 523 | 121 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.16e-03 | 9 | 121 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 1.16e-03 | 9 | 121 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.26e-03 | 451 | 121 | 9 | GO:0014069 | |
| Domain | SPEC | 4.21e-08 | 32 | 117 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.21e-08 | 32 | 117 | 6 | IPR018159 | |
| Domain | Spectrin | 2.72e-07 | 23 | 117 | 5 | PF00435 | |
| Domain | ACTININ_2 | 2.72e-07 | 23 | 117 | 5 | PS00020 | |
| Domain | ACTININ_1 | 2.72e-07 | 23 | 117 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.72e-07 | 23 | 117 | 5 | IPR001589 | |
| Domain | - | 3.02e-07 | 71 | 117 | 7 | 1.10.418.10 | |
| Domain | CH-domain | 4.41e-07 | 75 | 117 | 7 | IPR001715 | |
| Domain | Spectrin_repeat | 9.32e-07 | 29 | 117 | 5 | IPR002017 | |
| Domain | CH | 3.25e-06 | 65 | 117 | 6 | SM00033 | |
| Domain | CH | 5.02e-06 | 70 | 117 | 6 | PF00307 | |
| Domain | CH | 6.42e-06 | 73 | 117 | 6 | PS50021 | |
| Domain | - | ABCC3 ABCA13 TEP1 PAPSS1 GTPBP10 ABCA10 TRIM23 NPHP3 RAB2B DSEL DNAH5 NLRP4 DYNC1H1 SMC1B TJP3 | 6.53e-05 | 746 | 117 | 15 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCC3 ABCA13 TEP1 PAPSS1 GTPBP10 ABCA10 TRIM23 NPHP3 RAB2B DSEL KIF13A DNAH5 NLRP4 DYNC1H1 SMC1B TJP3 | 7.77e-05 | 848 | 117 | 16 | IPR027417 |
| Domain | Nicotinic_acetylcholine_rcpt | 1.26e-04 | 16 | 117 | 3 | IPR002394 | |
| Domain | EPS8_PTB | 2.32e-04 | 4 | 117 | 2 | IPR033928 | |
| Domain | ABC_transporter-like | 2.70e-04 | 50 | 117 | 4 | IPR003439 | |
| Domain | - | 3.87e-04 | 23 | 117 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 3.87e-04 | 23 | 117 | 3 | IPR027361 | |
| Domain | Znf_RING_CS | 5.67e-04 | 163 | 117 | 6 | IPR017907 | |
| Domain | GF_recep_IV | 5.74e-04 | 6 | 117 | 2 | PF14843 | |
| Domain | GF_recep_IV | 5.74e-04 | 6 | 117 | 2 | IPR032778 | |
| Domain | Peptidase_S8_Asp-AS | 5.74e-04 | 6 | 117 | 2 | IPR023827 | |
| Domain | P_proprotein | 8.00e-04 | 7 | 117 | 2 | PF01483 | |
| Domain | S8_pro-domain | 8.00e-04 | 7 | 117 | 2 | IPR032815 | |
| Domain | PrprotnconvertsP | 8.00e-04 | 7 | 117 | 2 | IPR002884 | |
| Domain | - | 8.00e-04 | 7 | 117 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 8.00e-04 | 7 | 117 | 2 | PF16470 | |
| Domain | ERAP1-like_C_dom | 1.06e-03 | 8 | 117 | 2 | IPR024571 | |
| Domain | DAD_dom | 1.06e-03 | 8 | 117 | 2 | IPR014767 | |
| Domain | PTB | 1.06e-03 | 8 | 117 | 2 | IPR013625 | |
| Domain | DHC_N1 | 1.06e-03 | 8 | 117 | 2 | PF08385 | |
| Domain | DAD | 1.06e-03 | 8 | 117 | 2 | PS51231 | |
| Domain | ERAP1_C | 1.06e-03 | 8 | 117 | 2 | PF11838 | |
| Domain | PTB | 1.06e-03 | 8 | 117 | 2 | PF08416 | |
| Domain | Dynein_heavy_dom-1 | 1.06e-03 | 8 | 117 | 2 | IPR013594 | |
| Domain | zf-B_box | 1.08e-03 | 72 | 117 | 4 | PF00643 | |
| Domain | Peptidase_S8_His-AS | 1.36e-03 | 9 | 117 | 2 | IPR022398 | |
| Domain | Drf_GBD | 1.36e-03 | 9 | 117 | 2 | PF06371 | |
| Domain | Drf_FH3 | 1.36e-03 | 9 | 117 | 2 | PF06367 | |
| Domain | PH_dom-spectrin-type | 1.36e-03 | 9 | 117 | 2 | IPR001605 | |
| Domain | Peptidase_S8_Ser-AS | 1.36e-03 | 9 | 117 | 2 | IPR023828 | |
| Domain | FH3_dom | 1.36e-03 | 9 | 117 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.36e-03 | 9 | 117 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.36e-03 | 9 | 117 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.36e-03 | 9 | 117 | 2 | SM01140 | |
| Domain | ZF_BBOX | 1.60e-03 | 80 | 117 | 4 | PS50119 | |
| Domain | Znf_B-box | 1.68e-03 | 81 | 117 | 4 | IPR000315 | |
| Domain | Glyco_transf_8 | 1.69e-03 | 10 | 117 | 2 | PF01501 | |
| Domain | Peptidase_S8_subtilisin-rel | 1.69e-03 | 10 | 117 | 2 | IPR015500 | |
| Domain | Glyco_trans_8 | 1.69e-03 | 10 | 117 | 2 | IPR002495 | |
| Domain | SUBTILASE_ASP | 1.69e-03 | 10 | 117 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 1.69e-03 | 10 | 117 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 1.69e-03 | 10 | 117 | 2 | PS00138 | |
| Domain | GBD/FH3_dom | 2.06e-03 | 11 | 117 | 2 | IPR014768 | |
| Domain | Fol_N | 2.06e-03 | 11 | 117 | 2 | IPR003645 | |
| Domain | - | 2.06e-03 | 11 | 117 | 2 | 3.40.50.200 | |
| Domain | GBD_FH3 | 2.06e-03 | 11 | 117 | 2 | PS51232 | |
| Domain | Peptidase_S8/S53_dom | 2.06e-03 | 11 | 117 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 2.06e-03 | 11 | 117 | 2 | PF00082 | |
| Domain | FOLN | 2.06e-03 | 11 | 117 | 2 | SM00274 | |
| Domain | AAA | 2.13e-03 | 144 | 117 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.13e-03 | 144 | 117 | 5 | IPR003593 | |
| Domain | ZF_RING_1 | 2.39e-03 | 291 | 117 | 7 | PS00518 | |
| Domain | ABC_A | 2.46e-03 | 12 | 117 | 2 | IPR026082 | |
| Domain | Peptidase_M1 | 2.46e-03 | 12 | 117 | 2 | IPR001930 | |
| Domain | ZF_RING_2 | 2.73e-03 | 298 | 117 | 7 | PS50089 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.81e-03 | 45 | 117 | 3 | IPR018000 | |
| Domain | Peptidase_M1_N | 2.90e-03 | 13 | 117 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 2.90e-03 | 13 | 117 | 2 | PF01433 | |
| Domain | Neur_chan_memb | 2.99e-03 | 46 | 117 | 3 | PF02932 | |
| Domain | RING | 3.11e-03 | 305 | 117 | 7 | SM00184 | |
| Domain | Neurotrans-gated_channel_TM | 3.18e-03 | 47 | 117 | 3 | IPR006029 | |
| Domain | - | 3.18e-03 | 47 | 117 | 3 | 2.70.170.10 | |
| Domain | WW | 3.18e-03 | 47 | 117 | 3 | PF00397 | |
| Domain | Neur_chan_LBD | 3.18e-03 | 47 | 117 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 3.18e-03 | 47 | 117 | 3 | PS00236 | |
| Domain | Neur_channel | 3.18e-03 | 47 | 117 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.18e-03 | 47 | 117 | 3 | IPR006202 | |
| Domain | - | 3.23e-03 | 391 | 117 | 8 | 2.30.29.30 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.37e-03 | 14 | 117 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.37e-03 | 14 | 117 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.37e-03 | 14 | 117 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.37e-03 | 14 | 117 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.37e-03 | 14 | 117 | 2 | IPR011704 | |
| Domain | PLAC | 3.37e-03 | 14 | 117 | 2 | PF08686 | |
| Domain | MT | 3.37e-03 | 14 | 117 | 2 | PF12777 | |
| Domain | AAA_8 | 3.37e-03 | 14 | 117 | 2 | PF12780 | |
| Domain | AAA_5 | 3.37e-03 | 14 | 117 | 2 | PF07728 | |
| Domain | ABC_tran | 3.38e-03 | 48 | 117 | 3 | PF00005 | |
| Domain | WW | 3.38e-03 | 48 | 117 | 3 | SM00456 | |
| Domain | ABC_TRANSPORTER_2 | 3.38e-03 | 48 | 117 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.58e-03 | 49 | 117 | 3 | PS00211 | |
| Domain | DHC_fam | 3.87e-03 | 15 | 117 | 2 | IPR026983 | |
| Domain | FH2 | 3.87e-03 | 15 | 117 | 2 | PS51444 | |
| Domain | Dynein_heavy | 3.87e-03 | 15 | 117 | 2 | PF03028 | |
| Domain | FH2_Formin | 3.87e-03 | 15 | 117 | 2 | IPR015425 | |
| Domain | FH2 | 3.87e-03 | 15 | 117 | 2 | PF02181 | |
| Domain | Dynein_heavy_dom | 3.87e-03 | 15 | 117 | 2 | IPR004273 | |
| Domain | FH2 | 3.87e-03 | 15 | 117 | 2 | SM00498 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.74e-05 | 11 | 88 | 3 | M883 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.97e-05 | 12 | 88 | 3 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.14e-05 | 14 | 88 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.01e-04 | 15 | 88 | 3 | MM14704 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 2.12e-04 | 19 | 88 | 3 | M47793 | |
| Pubmed | MYBBP1A TBC1D15 ANK3 RBBP6 SPTBN2 FNBP4 MPDZ CCNK JMJD1C GTF2E2 ANLN TLN1 PLEKHA5 DYNC1H1 | 1.01e-08 | 549 | 123 | 14 | 38280479 | |
| Pubmed | A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. | 1.72e-07 | 4 | 123 | 3 | 18385739 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 17434683 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 23613527 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 12079404 | ||
| Pubmed | MYBBP1A TBC1D15 ANK3 SYNE1 SF3A1 SPTBN2 FNBP4 MPDZ SPG11 FASTKD2 PTPN2 GTF2E2 LNPEP TLN1 NUP133 PLEKHA5 DAAM1 MRPL9 HERC5 | 1.22e-06 | 1487 | 123 | 19 | 33957083 | |
| Pubmed | ANK3 RBBP6 SYNE1 KIAA0232 SPTBN2 LAMA3 DST BRAF CEP95 PLEKHA5 DMD | 1.34e-06 | 486 | 123 | 11 | 20936779 | |
| Pubmed | MYBBP1A TBC1D15 ANK3 BZW2 SF3A1 MPDZ XPO1 CCNK JMJD1C DST TLN1 PLEKHA5 DYNC1H1 | 1.46e-06 | 708 | 123 | 13 | 39231216 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 8563774 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 9009220 | ||
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 2.39e-06 | 8 | 123 | 3 | 27344019 | |
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 8906617 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.55e-06 | 120 | 123 | 6 | 31413325 | |
| Pubmed | 5.09e-06 | 10 | 123 | 3 | 20736995 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANK3 RBBP6 ABCA13 GSDMB JMJD1C SERPINI2 ZMYND10 CEP95 PLEKHA5 | 5.89e-06 | 361 | 123 | 9 | 26167880 |
| Pubmed | 6.98e-06 | 11 | 123 | 3 | 12225896 | ||
| Pubmed | 9.28e-06 | 12 | 123 | 3 | 20584212 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 29993116 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 31599127 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 24486332 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18957677 | ||
| Pubmed | CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population. | 1.24e-05 | 2 | 123 | 2 | 29609626 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23918390 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19132693 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 37277853 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 15464228 | ||
| Pubmed | Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. | 1.24e-05 | 2 | 123 | 2 | 18227835 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21385908 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 20564069 | ||
| Pubmed | CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers. | 1.24e-05 | 2 | 123 | 2 | 26751916 | |
| Pubmed | A novel testis-specific Na+/H+ exchanger is involved in sperm motility and fertility. | 1.24e-05 | 2 | 123 | 2 | 20036903 | |
| Pubmed | In vivo RNA-RNA duplexes from human alpha3 and alpha5 nicotinic receptor subunit mRNAs. | 1.24e-05 | 2 | 123 | 2 | 15716100 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 27127891 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25051068 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21215707 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22653783 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 24675808 | ||
| Pubmed | A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. | 1.24e-05 | 2 | 123 | 2 | 20395203 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19409551 | ||
| Pubmed | A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes. | 1.24e-05 | 2 | 123 | 2 | 21748402 | |
| Pubmed | Intestinal Paneth cell differentiation relies on asymmetric regulation of Wnt signaling by Daam1/2. | 1.24e-05 | 2 | 123 | 2 | 38000028 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18061232 | ||
| Pubmed | Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine. | 1.24e-05 | 2 | 123 | 2 | 36078193 | |
| Pubmed | CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women. | 1.24e-05 | 2 | 123 | 2 | 24588897 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 20725741 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 32930707 | ||
| Pubmed | A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. | 1.24e-05 | 2 | 123 | 2 | 20643934 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 28868326 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8335106 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22017462 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8468318 | ||
| Pubmed | In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. | 1.24e-05 | 2 | 123 | 2 | 21858091 | |
| Pubmed | Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. | 1.24e-05 | 2 | 123 | 2 | 21559498 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22223462 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18450646 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19005185 | ||
| Pubmed | Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells. | 1.24e-05 | 2 | 123 | 2 | 23911934 | |
| Pubmed | CHRNA5/CHRNA3 gene cluster is a risk factor for lumbar disc herniation: a case-control study. | 1.24e-05 | 2 | 123 | 2 | 31362771 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19641473 | ||
| Pubmed | Nucleo-cytoplasmic shuttling of Axin, a negative regulator of the Wnt-beta-catenin Pathway. | 1.24e-05 | 2 | 123 | 2 | 14630927 | |
| Pubmed | 1.35e-05 | 506 | 123 | 10 | 30890647 | ||
| Pubmed | 1.53e-05 | 14 | 123 | 3 | 19059502 | ||
| Pubmed | 1.53e-05 | 407 | 123 | 9 | 12693553 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 1.63e-05 | 150 | 123 | 6 | 22678362 | |
| Pubmed | 1.70e-05 | 151 | 123 | 6 | 17043677 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.90e-05 | 15 | 123 | 3 | 8838678 | |
| Pubmed | MYBBP1A NPEPPS SF3A1 SPTBN2 FRYL XPO1 DST TLN1 NUP133 DYNC1H1 HERC5 | 2.17e-05 | 653 | 123 | 11 | 22586326 | |
| Pubmed | 2.34e-05 | 16 | 123 | 3 | 19259974 | ||
| Pubmed | 2.83e-05 | 17 | 123 | 3 | 37080995 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.39e-05 | 18 | 123 | 3 | 12119179 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.44e-05 | 565 | 123 | 10 | 25468996 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23844051 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 25471942 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 19671882 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22101982 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 24750073 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 21646606 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 38902419 | ||
| Pubmed | Combined analysis of CHRNA5, CHRNA3 and CYP2A6 in relation to adolescent smoking behaviour. | 3.71e-05 | 3 | 123 | 2 | 21765098 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 24833065 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 27302872 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 19429911 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22956269 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18618000 | ||
| Pubmed | Meta-analysis and imputation refines the association of 15q25 with smoking quantity. | 3.71e-05 | 3 | 123 | 2 | 20418889 | |
| Pubmed | Sodium-hydrogen exchanger NHA1 and NHA2 control sperm motility and male fertility. | 3.71e-05 | 3 | 123 | 2 | 27010853 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 11606319 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 21248747 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18414406 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 1572664 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 8670066 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 15494367 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22459873 | ||
| Pubmed | Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. | 3.71e-05 | 3 | 123 | 2 | 14981260 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 30453884 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23458267 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 19733931 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 20685379 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22336398 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18996504 | ||
| GeneFamily | Cholinergic receptors nicotinic subunits | 5.00e-05 | 16 | 83 | 3 | 173 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.31e-04 | 7 | 83 | 2 | 1113 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 7.34e-04 | 9 | 83 | 2 | 973 | |
| GeneFamily | Glycosyltransferase family 8 | 7.34e-04 | 9 | 83 | 2 | 436 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 9.57e-04 | 95 | 83 | 4 | 59 | |
| GeneFamily | Ring finger proteins | 1.66e-03 | 275 | 83 | 6 | 58 | |
| GeneFamily | ATP binding cassette subfamily A | 1.83e-03 | 14 | 83 | 2 | 805 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.71e-03 | 17 | 83 | 2 | 104 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.38e-03 | 24 | 83 | 2 | 485 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 7.73e-06 | 157 | 119 | 7 | M7733 | |
| Coexpression | GCNP_SHH_UP_EARLY.V1_UP | 1.51e-05 | 174 | 119 | 7 | M2639 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.18e-08 | 191 | 123 | 8 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.97e-08 | 194 | 123 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-07 | 185 | 123 | 7 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.06e-07 | 187 | 123 | 7 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.12e-06 | 193 | 123 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 123 | 7 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 123 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.42e-06 | 200 | 123 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 164 | 123 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.12e-06 | 171 | 123 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 171 | 123 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-05 | 180 | 123 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 182 | 123 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-05 | 182 | 123 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.19e-05 | 183 | 123 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.19e-05 | 183 | 123 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 184 | 123 | 6 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 184 | 123 | 6 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 184 | 123 | 6 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 185 | 123 | 6 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 185 | 123 | 6 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 185 | 123 | 6 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 186 | 123 | 6 | fef543f188edb0d1704d9c6ace366a0f8017bf53 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 187 | 123 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 187 | 123 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 188 | 123 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 188 | 123 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.39e-05 | 188 | 123 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 190 | 123 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 191 | 123 | 6 | b85a0978dc1e8af4f49423f56dcfd52efce09ed1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-05 | 192 | 123 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 192 | 123 | 6 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.62e-05 | 193 | 123 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.62e-05 | 193 | 123 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.62e-05 | 193 | 123 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 194 | 123 | 6 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 194 | 123 | 6 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.66e-05 | 194 | 123 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.71e-05 | 195 | 123 | 6 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-05 | 196 | 123 | 6 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-05 | 196 | 123 | 6 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.76e-05 | 196 | 123 | 6 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-05 | 196 | 123 | 6 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 197 | 123 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-05 | 197 | 123 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 197 | 123 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-05 | 197 | 123 | 6 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 198 | 123 | 6 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 198 | 123 | 6 | 428182c71f009906c581e02257e545ea5fb99650 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-05 | 199 | 123 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 199 | 123 | 6 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.92e-05 | 199 | 123 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-05 | 199 | 123 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Healthy_Control-Lymphoid-T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.92e-05 | 199 | 123 | 6 | f22438fc9c02d0a4d7c936f9420b913aca851ea1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 199 | 123 | 6 | 08bdcabc3fce787578a8eb66fc8412b0974fa6cc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.92e-05 | 199 | 123 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 199 | 123 | 6 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.97e-05 | 200 | 123 | 6 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | 26f07d271e984f375145e4c10528fba44a5811e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-05 | 200 | 123 | 6 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | c3637827ceba16b0d7956c280dd2ddbc8b1ba55e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.97e-05 | 200 | 123 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.97e-05 | 200 | 123 | 6 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.97e-05 | 200 | 123 | 6 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.97e-05 | 200 | 123 | 6 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.97e-05 | 200 | 123 | 6 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-05 | 134 | 123 | 5 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.09e-05 | 155 | 123 | 5 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.48e-05 | 161 | 123 | 5 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.73e-05 | 162 | 123 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-05 | 163 | 123 | 5 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-05 | 163 | 123 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-05 | 163 | 123 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-04 | 168 | 123 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 169 | 123 | 5 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 169 | 123 | 5 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 169 | 123 | 5 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 172 | 123 | 5 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 172 | 123 | 5 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 173 | 123 | 5 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 173 | 123 | 5 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.19e-04 | 173 | 123 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-04 | 173 | 123 | 5 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 173 | 123 | 5 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 123 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 175 | 123 | 5 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 175 | 123 | 5 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| Drug | plakin | 4.77e-06 | 82 | 120 | 6 | CID000018752 | |
| Drug | ethylpiperazine | 4.92e-06 | 7 | 120 | 3 | CID000079196 | |
| Drug | Dimethylphenylpiperazinium Iodide | 7.84e-06 | 8 | 120 | 3 | ctd:D004246 | |
| Drug | epibatidine | 7.84e-06 | 8 | 120 | 3 | ctd:C082748 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 8.69e-07 | 19 | 117 | 4 | DOID:9562 (implicated_via_orthology) | |
| Disease | Seizures, Focal | 3.78e-06 | 104 | 117 | 6 | C0751495 | |
| Disease | Smoking as a quantitative trait locus 3 | 1.56e-05 | 2 | 117 | 2 | cv:C3150168 | |
| Disease | – | 1.56e-05 | 2 | 117 | 2 | 612052 | |
| Disease | Congenital exomphalos | 1.56e-05 | 2 | 117 | 2 | C1306503 | |
| Disease | Congenital omphalocele | 1.56e-05 | 2 | 117 | 2 | C0795690 | |
| Disease | Tobacco Dependence | 2.14e-05 | 14 | 117 | 3 | C0040332 | |
| Disease | Nicotine Dependence | 2.14e-05 | 14 | 117 | 3 | C0028043 | |
| Disease | Nicotine Use Disorder | 2.14e-05 | 14 | 117 | 3 | C0376384 | |
| Disease | Gastrointestinal Stromal Tumors | 4.70e-05 | 50 | 117 | 4 | C0238198 | |
| Disease | Generalized seizures | 5.26e-05 | 101 | 117 | 5 | C0234533 | |
| Disease | Clonic Seizures | 5.26e-05 | 101 | 117 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 5.26e-05 | 101 | 117 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 5.26e-05 | 101 | 117 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 5.26e-05 | 101 | 117 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 5.26e-05 | 101 | 117 | 5 | C0751123 | |
| Disease | Complex partial seizures | 5.26e-05 | 101 | 117 | 5 | C0149958 | |
| Disease | Single Seizure | 5.26e-05 | 101 | 117 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 5.26e-05 | 101 | 117 | 5 | C3495874 | |
| Disease | Visual seizure | 5.26e-05 | 101 | 117 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 5.26e-05 | 101 | 117 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 5.26e-05 | 101 | 117 | 5 | C0422855 | |
| Disease | Gustatory seizure | 5.26e-05 | 101 | 117 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 5.26e-05 | 101 | 117 | 5 | C0422850 | |
| Disease | Olfactory seizure | 5.26e-05 | 101 | 117 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 5.26e-05 | 101 | 117 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 5.26e-05 | 101 | 117 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 5.26e-05 | 101 | 117 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 5.26e-05 | 101 | 117 | 5 | C4317109 | |
| Disease | Absence Seizures | 5.51e-05 | 102 | 117 | 5 | C4316903 | |
| Disease | Convulsions | 5.51e-05 | 102 | 117 | 5 | C4048158 | |
| Disease | Tonic Seizures | 5.51e-05 | 102 | 117 | 5 | C0270844 | |
| Disease | Myoclonic Seizures | 6.05e-05 | 104 | 117 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 6.05e-05 | 104 | 117 | 5 | C0494475 | |
| Disease | forced expiratory volume | MICAL1 ATP8B4 SYNE1 SPTBN2 JMJD1C CHRNA3 CHRNA5 DST CEP95 UHRF1 HERC5 PMFBP1 | 7.25e-05 | 789 | 117 | 12 | EFO_0004314 |
| Disease | Alcohol abuse | 1.48e-04 | 67 | 117 | 4 | C0085762 | |
| Disease | lung cancer (is_implicated_in) | 2.18e-04 | 74 | 117 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.18e-04 | 74 | 117 | 4 | DOID:3748 (is_marker_for) | |
| Disease | nicotine dependence (is_implicated_in) | 2.31e-04 | 6 | 117 | 2 | DOID:0050742 (is_implicated_in) | |
| Disease | X-16935 measurement | 3.23e-04 | 7 | 117 | 2 | EFO_0800763 | |
| Disease | Primary ciliary dyskinesia | 3.94e-04 | 36 | 117 | 3 | cv:C0008780 | |
| Disease | Adult Hepatocellular Carcinoma | 5.51e-04 | 9 | 117 | 2 | C0279607 | |
| Disease | Lung Neoplasms | 6.75e-04 | 265 | 117 | 6 | C0024121 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 6.87e-04 | 10 | 117 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | Malignant neoplasm of lung | 6.88e-04 | 266 | 117 | 6 | C0242379 | |
| Disease | Alcohol Use Disorder | 7.15e-04 | 44 | 117 | 3 | C0001956 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 8.38e-04 | 11 | 117 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Gastrointestinal Stromal Sarcoma | 8.68e-04 | 47 | 117 | 3 | C3179349 | |
| Disease | Primary Ciliary Dyskinesia | 8.68e-04 | 47 | 117 | 3 | C4551720 | |
| Disease | Liver carcinoma | 9.56e-04 | 507 | 117 | 8 | C2239176 | |
| Disease | Ciliopathies | 9.81e-04 | 110 | 117 | 4 | C4277690 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.00e-03 | 12 | 117 | 2 | C1861063 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.10e-03 | 195 | 117 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | susceptibility to bacterial meningitis measurement | 1.17e-03 | 52 | 117 | 3 | EFO_0008411 | |
| Disease | FEV/FEC ratio | PCSK5 ATP8B4 KIAA0232 DNER JMJD1C CHRNA3 CHRNA5 INPP4B SPTBN5 FCGBP DST KIF13A DNAH5 | 1.18e-03 | 1228 | 117 | 13 | EFO_0004713 |
| Disease | Polydactyly | 1.23e-03 | 117 | 117 | 4 | C0152427 | |
| Disease | ferritin measurement | 1.31e-03 | 119 | 117 | 4 | EFO_0004459 | |
| Disease | Saldino-Noonan Syndrome | 1.38e-03 | 14 | 117 | 2 | C0036069 | |
| Disease | tuberculosis | 1.73e-03 | 216 | 117 | 5 | MONDO_0018076 | |
| Disease | Astigmatism | 1.77e-03 | 129 | 117 | 4 | HP_0000483 | |
| Disease | Seizures | 1.80e-03 | 218 | 117 | 5 | C0036572 | |
| Disease | lung small cell carcinoma (is_marker_for) | 1.80e-03 | 16 | 117 | 2 | DOID:5409 (is_marker_for) | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.80e-03 | 16 | 117 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | 5-oxoproline measurement | 1.80e-03 | 16 | 117 | 2 | EFO_0010988 | |
| Disease | phosphatidylcholine 38:6 measurement | 1.80e-03 | 16 | 117 | 2 | EFO_0010388 | |
| Disease | Colorectal Carcinoma | 1.96e-03 | 702 | 117 | 9 | C0009402 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 2.03e-03 | 63 | 117 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.07e-03 | 225 | 117 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.32e-03 | 139 | 117 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Pancreatic carcinoma | 2.55e-03 | 19 | 117 | 2 | C0235974 | |
| Disease | emphysema pattern measurement | 2.55e-03 | 19 | 117 | 2 | EFO_0005850 | |
| Disease | emphysema imaging measurement | 2.77e-03 | 146 | 117 | 4 | EFO_0007626 | |
| Disease | Adenocarcinoma of prostate | 2.83e-03 | 20 | 117 | 2 | C0007112 | |
| Disease | Bronchiectasis | 3.42e-03 | 22 | 117 | 2 | C0006267 | |
| Disease | vital capacity | PCSK5 MICAL1 SYNE1 SPTBN2 DNER JMJD1C SEMA3D DST BRAF UHRF1 NLRP4 PMFBP1 | 3.72e-03 | 1236 | 117 | 12 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMNAVEWNKKEELVA | 301 | Q9Y6E2 | |
| EVWNIKQMIKLTQEH | 46 | P15056 | |
| EVNQIMETNLWLKQI | 76 | P32297 | |
| QQMWQILQATVKNKE | 1376 | Q8WWZ4 | |
| IQQLQKSIAWEKSIM | 1916 | Q9UIF8 | |
| PLLKDQVKSVMEQNW | 361 | Q8TAX9 | |
| LEKAITREAQMWKVN | 16 | Q14094 | |
| NKIQKLVQMAWTFVN | 176 | O75909 | |
| QKLLEFGNEVIWKMQ | 791 | Q86UQ4 | |
| DIENKMNSILKIVTW | 1426 | Q86UQ4 | |
| VLINSKLQNEKWMNV | 116 | Q8TF62 | |
| VKELMKQWQDLQGEI | 2731 | P11532 | |
| VMFITISIKVLWKNN | 641 | Q96K78 | |
| VAKQQTEEMWEVLKP | 366 | Q01459 | |
| GLNKVWINITEMNKQ | 146 | O75071 | |
| DEKNQVLTTNIWLQM | 66 | P36544 | |
| LKVQAKMESLVVSWQ | 636 | Q8TDY8 | |
| MQNIVQILESVQLKW | 281 | Q6P1R3 | |
| WEQLENAMVAVKTVV | 371 | Q9HBD1 | |
| RMVNIDGKQIKLQIW | 46 | Q8WUD1 | |
| VWQQKTKAVVMLNRI | 101 | P17706 | |
| MVVQQLLEAWRKQEK | 251 | O15438 | |
| LNKKQERDWVSVVMQ | 66 | O43827 | |
| IVNMLINENEVKQWR | 431 | Q86T65 | |
| WAEVVINVNNILKDM | 721 | Q8WUM0 | |
| DMEEWINIIKTIQQG | 296 | Q5KSL6 | |
| GLKKNQVVQLQEWMI | 376 | Q6P0N0 | |
| IGKLQKRMWINVDVQ | 2686 | Q16787 | |
| KRMWINVDVQNTIID | 2691 | Q16787 | |
| QLKQWLVEKELMVSV | 4636 | Q03001 | |
| KAVQDKLDQMVFIWE | 6126 | Q03001 | |
| TKEERDLWMQKLNQV | 1091 | Q9NQW6 | |
| QNIQSKKRKNVEIMW | 811 | O15327 | |
| VWVKEQKVQEIFMQG | 171 | Q15652 | |
| EWNEVKNVKSIVPMI | 1501 | O15054 | |
| MEPKVEWIQQQVVKK | 96 | Q92824 | |
| MDPQVKWLQQQEVKR | 131 | P29122 | |
| VCLQEIMTVWNKSKV | 186 | Q92628 | |
| NVIKKLWKQIMTTDD | 291 | A6NMZ5 | |
| EVKSAMQKLWVKIIT | 291 | P0C623 | |
| QKWQALAEQQEKMLI | 851 | O76074 | |
| NAVKMLVQLINQWKQ | 636 | O94915 | |
| LKVAVEQWKRQVMSE | 771 | Q5VZ66 | |
| VIQLNIQWMEKNLKS | 1006 | Q9UIQ6 | |
| LMITVQELNLEEKQW | 991 | Q8TDZ2 | |
| QRITKQLEKWMQKNV | 241 | Q9H1C3 | |
| QNITNQLEKWMKLNV | 256 | Q68CQ7 | |
| KEWLQVDFQKTMKVT | 2246 | P00451 | |
| QKLWMIQSQIQVIER | 246 | Q9HCJ2 | |
| KQMTLQLELKQIPWT | 31 | Q96MN2 | |
| MEQQKLNWKDTVVKS | 876 | Q6IE36 | |
| KIWTQEMLLQVNDQS | 86 | Q9H6S3 | |
| ESMKQQLLVLVEWAK | 141 | Q14541 | |
| QSITWQMIEQIQFVK | 296 | Q14541 | |
| EWKQLMGQVLAKVTE | 1051 | Q9BQG0 | |
| IIMIQVPQSKWDKDD | 1311 | Q7Z6E9 | |
| IFKELTQKDWITNMI | 451 | Q9UII4 | |
| TRKEKDWVIKVQMVQ | 191 | C9JE40 | |
| DWVIKVQMVQLQSAK | 196 | C9JE40 | |
| ALKINKVDMQWVQVL | 256 | O43252 | |
| VRMLVNENEVKQWKE | 436 | Q9Y4D1 | |
| VDEKNQLMTTNVWLK | 86 | P30532 | |
| VIKQVWTNAMKLSEK | 186 | B1AJZ9 | |
| KEENSKIMDVVFQWL | 226 | Q9Y366 | |
| WVVAQNRMTLKQLKD | 46 | A4D1E9 | |
| LERLKNNVMVIETWN | 871 | Q4AC94 | |
| KWQEVKEVLLQQSVM | 666 | Q8WTW3 | |
| WEQQQMRKAVKIIEE | 226 | P16383 | |
| QRQWKVTVNGVDMKL | 3726 | Q9Y6R7 | |
| AEKNQKIMQWIIEGE | 626 | O15169 | |
| KEIQMQLQEESVWVG | 416 | P54257 | |
| TWLRLQQEMVKVTQE | 776 | Q4G0X9 | |
| VEAEHQIMLWEKKIQ | 901 | Q4G0X9 | |
| IQAMEIKKDIWNTEG | 3436 | Q12955 | |
| PTLSKMWKQQIAQVE | 581 | Q96GE4 | |
| MWKQQIAQVEQLKKE | 586 | Q96GE4 | |
| LSKVWEQIDQMKEQP | 1336 | Q14204 | |
| AKGKVWTQDMILQVD | 96 | Q12929 | |
| KTGQKVVEMKWDQVE | 181 | Q8NFT8 | |
| ENLMVLIAIWKNNKF | 56 | Q99500 | |
| KANIWKQAVVDVMEK | 246 | Q8IZU8 | |
| MNVVLKNVKPDQWVK | 566 | P55786 | |
| CMKVWIKQTEQVLAE | 256 | Q8TE73 | |
| QVWTIEKLENKLIDM | 741 | Q9H1H9 | |
| IMTNLEQWAKQQKVA | 886 | Q8TBY8 | |
| IGLKQKQWLMTEALV | 111 | P29084 | |
| TAMRITKWKEKVQIQ | 161 | O00635 | |
| SQEKMKVQKIITNVW | 126 | A6NJY1 | |
| RLMEQKFQQVDEWLK | 3601 | Q8NF91 | |
| KRIEEWKQQQLVSGM | 976 | Q8N3X1 | |
| KFNVQVEKWVKQMIN | 281 | Q9UI40 | |
| VEKWVKQMINRNKVV | 286 | Q9UI40 | |
| DQVQQVEKHMKWLID | 626 | Q7Z494 | |
| VWKIEDVFTLQVVMK | 301 | Q9NYY8 | |
| AMQSLWNIKVAVLVK | 501 | O15357 | |
| LRNKVNWKTEIISEM | 906 | Q562F6 | |
| SIKVQVPNMQDKTEW | 706 | Q15459 | |
| LAEAWIQEKEVKMNV | 2266 | Q9NRC6 | |
| VLKVVSISKEKWNME | 476 | O95025 | |
| KSQWNVVKTVVVMLQ | 71 | Q86VW0 | |
| EIQQKVMQVVNWLEG | 276 | Q86VW0 | |
| ENQTLKIIAMIQWAV | 156 | A8MXE2 | |
| MKNNVKWELNPEIVA | 176 | Q9BYD2 | |
| EMQTLKHIEQWSLKQ | 1711 | Q96JI7 | |
| WKERVELIEKVITMQ | 151 | Q5EBN2 | |
| NMILVQILKQEWPKH | 131 | O14980 | |
| DIQMWKVSLQKEQAR | 746 | Q92574 | |
| QQSQVLWRMIAELKE | 236 | Q6AZZ1 | |
| MQWSKVTNKIDLIAV | 56 | P40200 | |
| GQLVLQDVWNMIQKL | 1096 | Q99973 | |
| QKQEAALLTKWQRIM | 531 | O75970 | |
| QTKLKWMQSELNVEE | 106 | Q4VC31 | |
| RVKQLTEKEWIQFMV | 346 | Q6IEE8 | |
| TSVNILLKKQQMLEW | 1416 | O15020 | |
| VATMTQQLEKLQWEQ | 386 | Q8NDV3 | |
| KKIIDSEWMQNVLGQ | 126 | Q8NE28 | |
| VWQLKNSAKVMVTNV | 2111 | Q9Y490 | |
| TRKWEQKQMQVKTLE | 166 | O15391 | |
| ITAQQILKWLSEMQE | 266 | O75830 | |
| QILFWIQEITEMDKK | 211 | Q5JUR7 | |
| EKMKVQKIITTVWDI | 361 | Q4ZJI4 | |
| MKLQWKSISQEQEKR | 386 | Q8TC07 | |
| ELVTQRKQDIFWKMV | 456 | O95049 | |
| IIKWQDLEVGQVVML | 211 | Q96T88 | |
| LWTVVAAIQAVEKKM | 41 | Q9UDV6 | |
| LVEELIAVEMWKQKV | 71 | O75800 | |
| EKLIWLRQQQEDMTI | 316 | P36406 | |
| WQRFKEVTNEMIVTK | 51 | O60806 | |
| AQIQKELWRIQDVME | 756 | Q9HAU0 | |
| GIQEIIQMNKSWVDI | 181 | Q9UN76 | |
| VQKILWEEPSNAVKM | 126 | A8MT65 | |
| IQMEQKRWIQLFKVI | 591 | Q15386 |